The Charing Cross International Symposium is one of the highlights of the vascular education calendar. This year's event took place April 15–18 at the Olympia Grand in London, UK. The conference featured 11 late-breaking abstracts, the summaries of which can be found below:

1. Two-year outcomes of complex iliac arterial disease with a balloon-expandable stent trial
   Michael Dake, Stanford, United States
2. BIOLUX P-III Trial: Passeo-18 Lux All-Comers Registry: 12-Month Results In BTK
   Gunnar Tepe, Rosenheim, Germany
3. Effectiveness Of Paclitaxel-Coated Balloon Catheter Vs. Uncoated Balloon Catheter In The SFA And PA To Prevent Restenosis Or Reocclusion: 12-Month Data
   Ulf Teichgraeber, Jena, Germany
4. BATTLE Late-Breaking Trial: One-Year Drug-Eluting Stent Vs. Bare Metal Stent
   Yann Gouëffic, Nantes, France
5. The EVRA trial: A Randomized Trial of Early Endovenous Ablation in Venous Ulceration
   Alun Davies, London, United Kingdom
6. LUTONIX AV IDE interim 24-month update
   Kate Steiner, Stevenage, United Kingdom
7. Risk factors for iliac limb occlusion – one-year data with latest generation EVAR device
   Mauro Gargiulo, Bologna, Italy
8. Next-generation conformable EVAR device with 90o angulated aortic neck
   Robert Rhee, New York, United States 
9. EVAS is associated with a reduction in all-cause mortality
   Marc Schermerhorn, Boston, United States
10. Podium 1st : Endovascular Custom Seal Ovation: Review Of Evidence For Avoiding FEVAR Or Parallel Graft Use
    Sean Lyden, Cleveland, United States
11. Podium 1st : Below-The-Knee Dedicated Sirolimus Eluting-Stent: 6-Month Results
    Kim Taeymans, Belgium